Role of Microglia in Glaucomatous Pathology
- PMID: 39930188
- PMCID: PMC12060067
- DOI: 10.1007/978-3-031-76550-6_25
Role of Microglia in Glaucomatous Pathology
Abstract
Glaucoma is a leading cause of irreversible blindness worldwide and is characterized by progressive loss of retinal ganglion cells. Much research has gone into further understanding the pathology of this disease, including the extent to which microglia modulate its pathogenesis. This has revealed a role of the innate immune system in glaucomatous pathology that begins before the onset of retinal ganglion cell dysfunction and degeneration. Stimulation of the innate immune response triggers downstream cascades implicated in chronic disease, making immune pathways invaluable in our understanding of glaucomatous pathology. This review will focus on evidence that supports the role of the microglial immunologic response in the pathogenesis of glaucoma.
Keywords: Astrocytes; Glaucoma; Immune system; Innate immunity; Microbiota; Microglia; Retinal ganglion cells.
© 2025. The Author(s), under exclusive license to Springer Nature Switzerland AG.
Conflict of interest statement
COI: Heidelberg Engineering, Topcon Inc. (CAG)
References
-
- Baudouin C, Kolko M, Melik-Parsadaniantz S, et al. Infammation in Glaucoma: from the back to the front of the eye, and beyond. Prog Retin Eye Res. 2021;83:100916. - PubMed
-
- Bosco A, Inman DM, Steele MR, et al. Reduced retina microglial activation and improved optic nerve integrity with minocycline treatment in the DBA/2J mouse model of glaucoma. Invest Ophthalmol Vis Sci. 2008;49:1437–46. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
